Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRTX

Mirati Therapeutics

$59.65

-1.5 (-2.45%)

16:51
08/01/18
08/01
16:51
08/01/18
16:51
Earnings
Mirati Therapeutics reports Q2 EPS (94c), consensus (78c) »

Reports Q2 revenue $0.00,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
MRTX

Mirati Therapeutics

$50.95

0.65 (1.29%)

07:24
07/20/18
07/20
07:24
07/20/18
07:24
Recommendations
Mirati Therapeutics analyst commentary at H.C. Wainwright »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$52.45

1.05 (2.04%)

08:08
07/09/18
07/09
08:08
07/09/18
08:08
Recommendations
Mirati Therapeutics analyst commentary at Oppenheimer »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$50.05

2.2 (4.60%)

07:37
07/05/18
07/05
07:37
07/05/18
07:37
Recommendations
Mirati Therapeutics analyst commentary at Citi »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DCPH

Deciphera

$41.02

2.34 (6.05%)

, LOXO

Loxo Oncology

$180.15

1.96 (1.10%)

07:26
07/05/18
07/05
07:26
07/05/18
07:26
Initiation
Deciphera, Loxo Oncology, Blueprint Medicines, Mirati Therapeutics initiated at SunTrust »

Deciphera initiated with…

DCPH

Deciphera

$41.02

2.34 (6.05%)

LOXO

Loxo Oncology

$180.15

1.96 (1.10%)

BPMC

Blueprint Medicines

$65.45

0.7 (1.08%)

MRTX

Mirati Therapeutics

$50.05

2.2 (4.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$48.75

1.55 (3.28%)

04:55
06/29/18
06/29
04:55
06/29/18
04:55
Conference/Events
Mirati Therapeutics management to meet with Oppenheimer »

Meeting to be held on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

MRTX

Mirati Therapeutics

$47.20

-2.85 (-5.69%)

04:55
06/28/18
06/28
04:55
06/28/18
04:55
Conference/Events
Mirati Therapeutics management to meet with Oppenheimer »

Meeting to be held on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

MRTX

Mirati Therapeutics

$49.20

-2.1 (-4.09%)

16:35
06/25/18
06/25
16:35
06/25/18
16:35
Hot Stocks
Mirati Therapeutics added to Russell 2000 Index »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

MRTX

Mirati Therapeutics

$51.45

0.95 (1.88%)

08:34
06/21/18
06/21
08:34
06/21/18
08:34
Conference/Events
Mirati Therapeutics management to meet with Oppenheimer »

Meeting to be held on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

MRTX

Mirati Therapeutics

$49.15

0.3 (0.61%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Recommendations
Mirati Therapeutics analyst commentary at SunTrust »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.